BlackRock Group’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$48K Hold
2016
Q3
$62K Hold
2016
Q2
$70K Hold
2016
Q1
$91K Hold
2015
Q4
$111K Hold
2015
Q3
$128K Hold
2015
Q2
$212K Sell
2015
Q1
$980K Hold
2014
Q4
$1.01M Hold
2014
Q3
$1.33M Buy
2014
Q2
$1.6M Hold
2014
Q1
$2M Hold
2013
Q4
$1.7M Hold
2013
Q3
$1.98M Buy
2013
Q2
$1.36M Buy